Genetic abnormalities in the DLBCL consensus clusters
. | OxPhos . | . | BCR/proliferation . | . | HR . | . | Total . | . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genetic abnormality* . | n = 37 . | % . | n = 50 . | % . | n = 29 . | % . | n = 116 . | % . | ||||
| t(14;18) | 8 | (22) | 5 | (10) | 1 | (3) | 14 | (12) | ||||
| t(3;...) | 2 | (5) | 8 | (16) | 1 | (3) | 11 | (9) | ||||
| None | 27 | (73) | 37 | (74) | 27 | (93) | 91 | (78) | ||||
. | OxPhos . | . | BCR/proliferation . | . | HR . | . | Total . | . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genetic abnormality* . | n = 37 . | % . | n = 50 . | % . | n = 29 . | % . | n = 116 . | % . | ||||
| t(14;18) | 8 | (22) | 5 | (10) | 1 | (3) | 14 | (12) | ||||
| t(3;...) | 2 | (5) | 8 | (16) | 1 | (3) | 11 | (9) | ||||
| None | 27 | (73) | 37 | (74) | 27 | (93) | 91 | (78) | ||||
116 tumors had available data and no more than one translocation. One OxPhos tumor with both translocations was omitted from the analysis. The distribution of genetic abnormalities across clusters was represented in a 3 × 3 contingency table and analyzed with a Fisher exact test (P = .059).